Hungarian Biotech Database

TOKYO, Oct. 4, 2019 /PRNewswire/ -- AI Medical Service Inc., one of the world's first real-time endoscopic artificial intelligence (AI) developers, today announced that it has raised approximately $42.9 million USD in Series B funding from Globis Capital Partners, World Innovation Lab (WiL) and... Read more ››

By: PR Newswire Association LLC. - 04 Oct 2019

Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

By: Nasdaq / GlobenewsWire - 30 Sep 2019

Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis

By: Nasdaq / GlobenewsWire - 20 Sep 2019

Sanofi: information concerning the total number of voting rights and shares, August 2019

By: Nasdaq / GlobenewsWire - 16 Sep 2019

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

By: Nasdaq / GlobenewsWire - 16 Sep 2019

Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9

By: Nasdaq / GlobenewsWire - 28 Aug 2019

Sanofi: information concerning the total number of voting rights and shares, July 2019

By: Nasdaq / GlobenewsWire - 19 Aug 2019

Sanofi : Dupixent® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis

By: Nasdaq / GlobenewsWire - 06 Aug 2019

Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis

By: Nasdaq / GlobenewsWire - 06 Aug 2019

Sanofi : Online Availability of Sanofi Group’s Half-Year Financial Report for 2019

By: Nasdaq / GlobenewsWire - 29 Jul 2019

Sanofi delivered solid growth in Q2 2019

By: Nasdaq / GlobenewsWire - 29 Jul 2019

Sanofi : Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon

By: Nasdaq / GlobenewsWire - 26 Jul 2019

Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer

By: Nasdaq / GlobenewsWire - 26 Jul 2019

Sanofi Announces Participation in 2nd China International Import Expo

SHANGHAI, July 26, 2019 /PRNewswire/ -- At today's Matchmaking Meeting for Medical Devices and Medical Health Care Exhibitors and Buyers of the 2(nd) China International Import Expo (CIIE), Sanofi officially announced that it would participate in the 2(nd) CIIE held in the National Convention... Read more ››

By: PR Newswire Association LLC. - 26 Jul 2019

1 2 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

November 2019
- Austria: 3rd Annual Inhalation & Respiratory Drug Products Summit
- Duesseldorf: DxPx Conference 2019
- Krakow: Life Science Open Space 2019

See Events »

Add an Event »

Latest company news

Sanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older
04 Nov 2019 (Nasdaq / GlobenewsWire)

Sanofi : Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
04 Nov 2019 (Nasdaq / GlobenewsWire)

Sanofi Q3 well on track
31 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news